Literature DB >> 18379591

Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor.

Alexey E Granovsky1, Marsha Rich Rosner.   

Abstract

Cells have a multitude of controls to maintain their integrity and prevent random switching from one biological state to another. Raf Kinase Inhibitory Protein (RKIP), a member of the phosphatidylethanolamine binding protein (PEBP) family, is representative of a new class of modulators of signaling cascades that function to maintain the "yin yang" or balance of biological systems. RKIP inhibits MAP kinase (Raf-MEK-ERK), G protein-coupled receptor (GPCR) kinase and NFkappaB signaling cascades. Because RKIP targets different kinases dependent upon its state of phosphorylation, RKIP also acts to integrate crosstalk initiated by multiple environmental stimuli. Loss or depletion of RKIP results in disruption of the normal cellular stasis and can lead to chromosomal abnormalities and disease states such as cancer. Since RKIP and the PEBP family have been reviewed previously, the goal of this analysis is to provide an update and highlight some of the unique features of RKIP that make it a critical player in the regulation of cellular signaling processes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379591     DOI: 10.1038/cr.2008.43

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  65 in total

1.  Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.

Authors:  Jin Sun Kim; Gwang Hyeon Choi; Yusun Jung; Kang Mo Kim; Se-Jin Jang; Eun Sil Yu; Han Chu Lee
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-01       Impact factor: 4.553

2.  Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma.

Authors:  Evan J Walker; Stephen A Rosenberg; Jack R Wands; Miran Kim
Journal:  For Immunopathol Dis Therap       Date:  2011

Review 3.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

4.  Cilia movement regulates expression of the Raf-1 kinase inhibitor protein.

Authors:  Kelli M Sas; Michael G Janech; Elizabeth Favre; John M Arthur; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-23

5.  Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma.

Authors:  Stavroula Baritaki; Sara Huerta-Yepez; Ma da Lourdas Cabrava-Haimandez; Marialuisa Sensi; Silvana Canevari; Massimo Libra; Manuel Penichet; Haiming Chen; James R Berenson; Benjamin Bonavida
Journal:  For Immunopathol Dis Therap       Date:  2011-04-01

6.  Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.

Authors:  Yinting Chen; Guoda Lian; Guangsheng Ou; Kege Yang; Jianning Chen; Haigang Li; Shaojie Chen; Jiajia Li; Linjuan Zeng; Kaihong Huang
Journal:  Gastric Cancer       Date:  2015-03-13       Impact factor: 7.370

7.  Phosphatidylenthanolamine Binding Protein aka Raf Kinase Inhibitor Protein: A Brief History of Its Discovery and the Remarkable Diversity of Biological Functions.

Authors:  John M Sedivy
Journal:  For Immunopathol Dis Therap       Date:  2011

8.  A proteomic study of cMyc improvement of CHO culture.

Authors:  Darrin Kuystermans; Michael J Dunn; Mohamed Al-Rubeai
Journal:  BMC Biotechnol       Date:  2010-03-22       Impact factor: 2.563

9.  Loss of RKIP expression is associated with poor survival in GISTs.

Authors:  Olga Martinho; António Gouveia; Paula Silva; Amadeu Pimenta; Rui Manuel Reis; José Manuel Lopes
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

10.  Two-dimensional gel proteome reference map of human small intestine.

Authors:  Maria Paola Simula; Renato Cannizzaro; Maria Dolores Marin; Alessandro Pavan; Giuseppe Toffoli; Vincenzo Canzonieri; Valli De Re
Journal:  Proteome Sci       Date:  2009-03-19       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.